DEERFIELD MANAGEMENT COMPANY, L.P. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001009258

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2024 · 363 positions · Total reported value $5.35B · Top-10 concentration 55.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 38.6% · 10 new · 12 cut · 12 exited

Active Share (vs S&P 500): 99.6% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +17.1% · vs SPY +2.2% · Prev Value $7.59B — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2024 13F filing, DEERFIELD MANAGEMENT COMPANY, L.P. disclosed 363 equity positions with a combined reported value of $5.35B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 55.0% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2024 were NUVL ($1.50B), VTRS ($255.46M), CNC ($186.86M). By sector, the heaviest allocations are Health Care 53.4%, Industrials 1.4%. Versus the prior quarter, allocation shifted away from Health Care (-0.5pp).

Versus the prior quarter, DEERFIELD MANAGEMENT COMPANY, L.P. opened 10 new positions, trimmed 12 and fully exited 12, a turnover rate of 38.6% of positions. The portfolio's overlap with the prior quarter was 31% of names.

The largest new positions opened in Q1 2024 were BNTX ($52.54M), KYTX ($36.32M), CATX ($33.53M).

Of the 12 positions fully exited versus the prior quarter, the largest were GKOS ($414.91M), NTRA ($172.44M), RYZB ($62.55M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • BNTX BIONTECH SE · $52.54M
  • KYTX KYVERNA THERAPEUTICS INC · $36.32M
  • CATX PERSPECTIVE THERAPEUTICS INC · $33.53M
  • SLDB SOLID BIOSCIENCES INC COM NEW · $30.11M
  • INMD INMODE LTD · $25.21M
  • ACCD ACCOLADE INC · $24.96M
  • AUTL AUTOLUS THERAPEUTICS LTD · $23.22M
  • APGE APOGEE THERAPEUTICS INC · $21.86M

Fully Exited (vs previous quarter)

  • GKOS GLAUKOS CORP · prev qtr: $414.91M
  • NTRA NATERA INC · prev qtr: $172.44M
  • RYZB RAYZEBIO INC · prev qtr: $62.55M
  • CMAX CAREMAX INC · prev qtr: $7.91M
  • NYXH NYXOAH S A · prev qtr: $811.27K
  • TRS TRIMAS CORP · prev qtr: $554.63K
  • PPC PILGRIMS PRIDE CORP NEW · prev qtr: $552.09K
  • JNJ JOHNSON & JOHNSON · prev qtr: $510.03K

Insider Transactions (Form 4)

Latest DEERFIELD MANAGEMENT COMPANY, L.P. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-07-15 D Nuvalent, Inc. 3,444 $124.00 SEC filing
2026-07-15 U Nuvalent, Inc. 5,146 $124.00 SEC filing
2026-07-15 D Nuvalent, Inc. 650,000 $124.00 SEC filing
2026-07-15 D Nuvalent, Inc. 8,299,225 $124.00 SEC filing
2026-06-16 Award Nuvalent, Inc. 3,444 — SEC filing
2026-06-11 Conversion Parabilis Medicines, Inc. 407,132 — SEC filing
2026-06-11 Conversion Parabilis Medicines, Inc. 260,992 — SEC filing
2026-06-11 Conversion Parabilis Medicines, Inc. 149,238 — SEC filing

All insider transactions →

Fund Profile

Deerfield Management Company, L.P. is a New York-based hedge fund founded by Marianne and James Chadwin, known for its quantitative and fundamental research approach focused primarily on healthcare and biotechnology investments.

Investment Approach

Combines quantitative analysis with fundamental research

Specializes in healthcare and biotechnology sectors

Utilizes both public and private investment strategies

Asset Classes & Strategy

Primarily focused on long/short equity positions

Specializes in healthcare and biotechnology investments

Also invests in other sectors with strong fundamental research

Key Personnel

Marianne Chadwin (Co-founder)

James Chadwin (Co-founder)

Team of experienced portfolio managers and researchers

AUM & Performance

Manages approximately $19.1 billion in assets under management

Performance data not publicly disclosed

All information is based on publicly available SEC filings and company disclosures.

Sector Allocation

Health Care 53.4%
Technology 0.3%
Financials 0.2%
Energy 0.0%
Other 44.1%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 19.99M $1.50B 28.08%
28.08%
Hold
2 21.40M $255.46M 4.78%
4.78%
Add
3 2.38M $186.86M 3.50%
3.50%
Add
4 21.23M $161.15M 3.02%
3.02%
Add
5 13.26M $152.60M 2.85%
2.85%
Reduce
6 9.13M $145.55M 2.72%
2.72%
Add
7 9.37M $139.38M 2.61%
2.61%
Reduce
8 6.40M $136.47M 2.55%
2.55%
Hold
9 4.88M $135.16M 2.53%
2.53%
Reduce
10 116.95M $124.39M 2.33%
2.33%
Hold
11 2.65M $119.30M 2.23%
2.23%
Reduce
12 5.41M $115.43M 2.16%
2.16%
Add
13 2.63M $115.42M 2.16%
2.16%
Hold
14 11.08M $113.22M 2.12%
2.12%
Hold
15 15.61M $103.20M 1.93%
1.93%
Add
16 3.09M $99.59M 1.86%
1.86%
Hold
17 691.00K $95.30M 1.78%
1.78%
Reduce
18 3.19M $95.06M 1.78%
1.78%
Add
19 5.13M $80.65M 1.51%
1.51%
Reduce
20 4.00M $66.59M 1.25%
1.25%
Hold
21 1.28M $63.16M 1.18%
1.18%
Reduce
22 5.00M $58.22M 1.09%
1.09%
Hold
23 5.19M $56.15M 1.05%
1.05%
Add
24 152.38K $52.70M 0.99%
0.99%
Add
25 569.57K $52.54M 0.98%
0.98%
New
26 2.87M $52.43M 0.98%
0.98%
Reduce
27 1.47M $52.22M 0.98%
0.98%
Add
28 1.41M $45.43M 0.85%
0.85%
Add
29 1.03M $44.30M 0.83%
0.83%
Add
30 665.53K $41.44M 0.78%
0.78%
Add
31 8.27M $41.02M 0.77%
0.77%
Add
32 463.50K $38.01M 0.71%
0.71%
Reduce
33 1.46M $36.32M 0.68%
0.68%
New
34 2.73M $36.18M 0.68%
0.68%
Add
35 28.18M $33.53M 0.63%
0.63%
New
36 2.26M $30.11M 0.56%
0.56%
New
37 1.77M $29.16M 0.55%
0.55%
Hold
38 338.17K $27.08M 0.51%
0.51%
Add
39 5.00M $25.37M 0.47%
0.47%
Add
40 1.17M $25.21M 0.47%
0.47%
New
41 2.38M $24.96M 0.47%
0.47%
New
42 1.06M $24.53M 0.46%
0.46%
Add
43 3.64M $23.22M 0.43%
0.43%
New
44 329.00K $21.86M 0.41%
0.41%
New
45 1.26M $21.47M 0.40%
0.40%
Reduce
46 5.10M $20.62M 0.39%
0.39%
Reduce
47 928.02K $20.56M 0.39%
0.39%
Reduce
48 4.13M $19.59M 0.37%
0.37%
Hold
49 3.54M $19.48M 0.36%
0.36%
New
50 1.14M $19.40M 0.36%
0.36%
New

FAQ

What did DEERFIELD MANAGEMENT COMPANY, L.P. buy in 2024-Q1?

In its 2024-Q1 13F filing, DEERFIELD MANAGEMENT COMPANY, L.P. reported 363 equity positions worth $5.35B in aggregate; its largest disclosed positions were NUVL ($1.50B), VTRS ($255.46M), CNC ($186.86M).

How large is DEERFIELD MANAGEMENT COMPANY, L.P.'s portfolio?

DEERFIELD MANAGEMENT COMPANY, L.P. reported $5.35B of long equity holdings across 363 positions as of 2024-Q1. Top-10 holdings account for 55.0% of reported value.

What is DEERFIELD MANAGEMENT COMPANY, L.P.'s investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/deerfield-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →